BioSpace News Archive

Lytix Biopharma AS, a Norwegian immuno-oncology company, will release its fourth quarter and second half 2022 results on Thursday, 16 February 2023 at 8am CEST.

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and global pharmaceutical company STADA Arzneimittel announced that the European Medicines Agency has accepted a Marketing Authorization Application for AVT04, Alvotech’s proposed biosimilar to Stelara®.

ARS Pharmaceuticals, Inc. today reported that Richard Lowenthal, M.Sc., MSEL, co-founder and chief executive officer, and Eric Karas, chief commercial officer, will participate in a fireside chat during the SVB Securities Virtual Global Biopharma Conference 2023.

Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology, today announced financial results for its fiscal 2023 first quarter and provided a business update.

Asensus Surgical, Inc. announced that President and CEO Anthony Fernando will be joined by other leaders of the Company to ring the opening bell of the New York Stock Exchange on February 21, 2023.

Voyager Therapeutics, Inc. today announced that management will participate in the following investor conferences.

Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 14-16, 2023 in Snowbird, Utah.

Aldeyra Therapeutics, Inc. today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the SVB Securities Global Biopharma Conference.

BioReference® Health LLC announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from Roche Diagnostics.

Ensoma today announced the closing of its previously announced acquisition of Twelve Bio ApS.